共 13 条
[1]
Classification and natural history of clinically identifiable subtypes of cerebral infarction. Bamford J,Sandercock P,Dennis M,et al. The Lancet . 1991
[2]
YKL-40-an emerging biomarker in cardiovascular disease and diabetes. Rathcke CN,Vestergaard H. Cardiovascular Diabetology . 2009
[3]
YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. Létuvé S,Kozhich A,Arouche N,Grandsaigne M,Reed J,Dombret MC,Kiener PA,Aubier M,Coyle AJ,Pretolani M. JImmunol . 2008
[4]
Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. JS Johansen. Danish Medical Bulletin . 2006
[5]
In vivo CHI3L1(YKL-40)expression in astrocytes in acute and chronic neuro-logical diseases. Bonneh-Barkay D,Wang G,Starkey A,et al. J Neuroinflammation . 2010
[6]
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[7]
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[8]
Plasma YKL-40andrecovery of left ventricular function after acute myocardial in-farction. Hedegaard A,Ripa RS,Johansen JS,et al. Scandinavian Journal of Clinical and Laboratory Investigation . 2010
[9]
Role of inflammatory markers inbrain ischemia. Rodriguez-Yanez M,Castillo J. Current Opinion in Neurology . 2008